A look into Mannkind Corp (MNKD)’s deeper side

With 4.04 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.2 million shares. The 52-week range on MNKD shows that it touched its highest point at $5.75 and its lowest point at $3.17 during that stretch. It currently has a 1-year price target of $7.08. Beta for the stock currently stands at 1.33.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MNKD was down-trending over the past week, with a drop of -12.04%, but this was down by -4.22% over a month. Three-month performance surged to 18.41% while six-month performance rose 4.36%. The stock gained 8.02% in the past year, while it has gained 18.41% so far this year. A look at the trailing 12-month EPS for MNKD yields -0.05 with Next year EPS estimates of 0.23. For the next quarter, that number is 0.03. This implies an EPS growth rate of 385.42% for this year and 101.31% for next year. EPS is expected to grow by 35.60% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 40.58%.

Float and Shares Shorts:

At present, 270.03 million MNKD shares are outstanding with a float of 260.22 million shares on hand for trading. On Mar 15, 2024, short shares totaled 33.05 million, which was 12.22% higher than short shares on Feb 15, 2024. In addition to Dr. Michael E. Castagna Pharm.D. as the firm’s CEO & Director, Mr. Steven B. Binder serves as its Chief Financial Officer.

Institutional Ownership:

Through their ownership of 50.23% of MNKD’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for MNKD since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, MNKD has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and MNKD currently yields $0.00. In the past year, MNKD’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, MNKD has a current buyback yield of $––. This was $–– for the TTM, and it was $–– for the past five years.